Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COUMARIN 7-HYDROXYLASE ACTIVITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 27 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hoffman, SMG; Nelson, DR; Keeney, DS
      Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19

      PHARMACOGENETICS
    2. Raunio, H; Rautio, A; Gullsten, H; Pelkonen, O
      Polymorphisms of CYP2A6 and its practical consequences

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    3. Mori, Y; Koide, A; Fuwa, K; Kobayashi, Y
      N-Benzylimidazole for preparation of S9 fraction with multi-induction of metabolizing enzymes in short-term genotoxicity assays

      MUTAGENESIS
    4. Gilmore, J; Rotondo, F; Pelletier, AM; LaMarre, J; Alaoui-Jamali, M; Kirby, GM
      Identification of a 43-kDa protein in human liver cytosol that binds to the 3 '-untranslated region of CYP2A6 mRNA

      BIOCHEMICAL PHARMACOLOGY
    5. Sivapathasundaram, S; Magnisali, P; Coldham, NG; Howells, LC; Sauer, MJ; Ioannides, C
      A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver

      BIOCHEMICAL PHARMACOLOGY
    6. Aoki, K; Takimoto, M; Ota, H; Yoshida, T
      Participation of CYP2A in cocaine-induced hepatotoxicity in female mice

      PHARMACOLOGY & TOXICOLOGY
    7. Bourian, M; Gullsten, H; Legrum, W
      Genetic polymorphism of CYP2A6 in the German population

      TOXICOLOGY
    8. Sellers, EM; Kaplan, HL; Tyndale, RF
      Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    9. Lewis, DFV; Dickens, M; Lake, BG; Eddershaw, PJ; Tarbit, MH; Goldfarb, PS
      Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity

      TOXICOLOGY
    10. Nunoya, K; Yokoi, T; Kimura, K; Kainuma, T; Satoh, K; Kinoshita, M; Kamataki, T
      A new CYP2A6 gene deletion responsible for the in vivo polymorphic metabolism of (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride inhumans

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    11. YOKOI T; KAMATAKI T
      GENETIC-POLYMORPHISM OF DRUG-METABOLIZING-ENZYMES - NEW MUTATIONS IN CYP2D6 AND CYP2A6 GENES IN JAPANESE

      Pharmaceutical research
    12. KOJO A; VIITALA P; PASANEN M; PELKONEN O; RAUNIO H; JUVONEN R
      INDUCTION OF CYP2A5 BY PYRAZOLE AND ITS DERIVATIVES IN MOUSE PRIMARY HEPATOCYTES

      Archives of toxicology
    13. STRESSER DM; KUPFER D
      HUMAN CYTOCHROME P450-CATALYZED CONVERSION OF THE PROESTROGENIC PESTICIDE METHOXYCHLOR INTO AN ESTROGEN - ROLE OF CYP2C19 AND CYP1A2 IN O-DEMETHYLATION

      Drug metabolism and disposition
    14. HICKMAN D; WANG JP; WANG Y; UNADKAT JD
      EVALUATION OF THE SELECTIVITY OF IN-VITRO PROBES AND SUITABILITY OF ORGANIC-SOLVENTS FOR THE MEASUREMENT OF HUMAN CYTOCHROME-P450 MONOOXYGENASE ACTIVITIES

      Drug metabolism and disposition
    15. Smith, G; Stubbins, MJ; Harries, LW; Wolf, CR
      Molecular genetics of the human cytochrome P450 monooxygenase superfamily

      XENOBIOTICA
    16. HONKAKOSKI P; NEGISHI M
      THE STRUCTURE, FUNCTION, AND REGULATION OF CYTOCHROME-P450 2A ENZYMES

      Drug metabolism reviews
    17. PASANEN M; RANNALA Z; TOOMING A; SOTANIEMI EA; PELKONEN O; RAUTIO A
      HEPATITIS-A IMPAIRS THE FUNCTION OF HUMAN HEPATIC CYP2A6 IN-VIVO

      Toxicology
    18. KOENIGS LL; PETER RM; THOMPSON SJ; RETTIE AE; TRAGER WF
      MECHANISM-BASED INACTIVATION OF HUMAN LIVER CYTOCHROME-P450 2A6 BY 8-METHOXYPSORALEN

      Drug metabolism and disposition
    19. KOJO A; PELLINEN P; JUVONEN R; RAUNIO H; PELKONEN O; PASANEN M
      DISTINCT RESPONSES OF MOUSE HEPATIC CYP ENZYMES TO CORN-OIL AND PEROXISOME PROLIFERATORS

      Biochemical pharmacology
    20. PELKONEN O; RAUNIO H
      INDIVIDUAL EXPRESSION OF CARCINOGEN-METABOLIZING ENZYMES - CYTOCHROMEP4502A

      Journal of occupational and environmental medicine
    21. FERNANDEZSALGUERO P; GONZALEZ FJ
      THE CYP 2A GENE SUBFAMILY - SPECIES-DIFFERENCES, REGULATION, CATALYTIC ACTIVITIES AND ROLE IN CHEMICAL CARCINOGENESIS

      Pharmacogenetics
    22. SALONPAA P; KRAUSE K; PELKONEN O; RAUNIO H
      UP-REGULATION OF CYP2A5 EXPRESSION BY PORPHYRINOGENIC AGENTS IN MOUSE-LIVER

      Naunyn-Schmiedeberg's archives of pharmacology
    23. KIMONEN T; JUVONEN RO; ALHAVA E; PASANEN M
      THE INHIBITION OF CYP ENZYMES IN MOUSE AND HUMAN LIVER BY PILOCARPINE

      British Journal of Pharmacology
    24. PELLINEN P; STENBACK F; RAUNIO H; PELKONEN O; PASANEN M
      MODIFICATION OF HEPATIC CYTOCHROME-P450 PROFILE BY COCAINE-INDUCED HEPATOTOXICITY IN DBA 2 MOUSE/

      European journal of pharmacology. Environmental toxicology and pharmacology section
    25. PELLINEN P; STENBACK F; RAUNIO H; PELKONEN O; PASANEN M
      MODIFICATION OF HEPATIC CYTOCHROME-P450 PROFILE BY COCAINE-INDUCED HEPATOTOXICITY IN DBA 2 MOUSE/

      European journal of pharmacology. Environmental toxicology and pharmacology section
    26. DUESCHER RJ; ELFARRA AA
      HUMAN LIVER-MICROSOMES ARE EFFICIENT CATALYSTS OF 1,3-BUTADIENE OXIDATION - EVIDENCE FOR MAJOR ROLES BY CYTOCHROMES P450 2A6 AND 2E1

      Archives of biochemistry and biophysics
    27. SALONPAA P; HAKKOLA J; PASANEN M; PELKONEN O; VAHAKANGAS K; BATTULA N; NOUSO K; RAUNIO H
      RETROVIRUS-MEDIATED STABLE EXPRESSION OF HUMAN CYP2A6 IN MAMMALIAN-CELLS

      European journal of pharmacology. Environmental toxicology and pharmacology section


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 08:47:21